Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangxi Medical University

Clinical trials sponsored by Guangxi Medical University, explained in plain language.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

Immunotherapy combo aims to boost survival in tough head & neck cancer

Disease control Ongoing

This study is testing whether adding an immunotherapy drug (a PD-1 inhibitor) to standard chemotherapy before a patient's main cancer treatment can help people with advanced nasopharyngeal cancer live longer without their cancer returning. It involves 150 participants who are ran…

Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control

Last updated Mar 17, 2026 13:10 UTC